Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Corey Ho

Diagnostic Radiology Aurora, CO Medical Doctor

NPI 1598041162 CMS profile 3350542

12605 E 16Th Ave, Aurora, CO 80045

Open in the dashboard

General payments

$8,157

50 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$25,072 paid to institutions, not to them · program years 2021–2022

Through program year 2024, Corey Ho of Aurora, CO is reported in the CMS Open Payments database as having received $8,157 across 50 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $25,072 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 92nd percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $200 1
2023 General $4,053 12
2022 General $2,755 25
2021 General $285 4
2020 General $162 4
2019 General $701 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Corey Ho
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Corey Ho were reported at $0. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Corey Ho Diagnostic Radiology median Middle half National median
2019 $701 $108 $29–$318 $163
2020 $162 $65 $21–$252 $114
2021 $285 $92 $24–$292 $132
2022 $2,755 $104 $29–$294 $149
2023 $4,053 $110 $29–$337 $160
2024 $200 $113 $30–$356 $164
2025 $0 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Stryker Corporation $6,617 25 payments
  2. Boston Scientific Corporation $1,300 17 payments
  3. Medtronic, Inc. $208 7 payments
  4. AngioDynamics, Inc. $31 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Consulting Fee $3,800 2 payments
  2. Travel and Lodging $2,615 10 payments
  3. Food and Beverage $1,742 38 payments
Products named General payments · program years 2019–2024
  1. MULTIGEN 2 $3,689 2 payments
  2. AUTOPLEX $3,635 3 payments
  3. OMNICURVE $3,600 1 payment
  4. SPINEJACK Interventional Spine $1,534 9 payments
  5. IVS - VERTEBRAL AUGMENTATION PRODUCTS $762 7 payments
  6. General - Therapies $650 5 payments
  7. Visual-ICE MRI Cryoablation Console $315 6 payments
  8. OPTABLATE $220 2 payments
  9. SPINEJACK Spine $220 2 payments
  10. PCD $200 1 payment
  11. Other $635 13 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 124 billing codes

Paid by Medicare

$91,873

Of which drugs: $436

Medicare patients

2,783

Average age 74

Services billed

6,209

1,682 women, 1,101 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 73%
High blood pressure 68%
Depression 27%
Diabetes 25%
Chronic kidney disease 24%
Ischemic heart disease 23%
Osteoporosis 19%
Atrial fibrillation 18%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, gadobutrol, 0.1 ml A9585 Office 16 1,313 $320

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

50 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record